Top Institutional Investors

Knott David M Jr — 13F Holdings & Portfolio

CIK 1892770 · latest 13F-HR filed 2026-08-12

Backtest portfolio

Knott David M Jr manages $189.2M in 13F-reported U.S. long-equity assets across 86 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are GOOG (17.03%), APO (14.07%), SNDX (5.05%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 11 new positions, exited 12, added to 40, and trimmed 16.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Filer Information
Address
DORSET PARTNERS LLC
485 UNDERHILL BOULEVARD, SUITE 205
SYOSSET, NY 11791
Phone
(516) 364-0303
Filing Manager
Knott David M Jr
SYOSSET, NY
Signatory
Knott David M Jr
Investment Manager
Loading holdings…
AUM

$189.2M

Long-equity book

Holdings

86

Distinct positions

Period

2026-06-30

Filed 2026-08-12

Q/Q Activity

+11 / −12 / ↑40 / ↓16

vs 2026-03-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • Alphabet Inc-Cl C$6.1M +23.2%
  • Travere Therapeutics, Inc.$4.2M +100.3%
  • Xeris Biopharma Holdings, Inc.$2.2M +36.6%
  • Alkermes PLC$2.1M +50.3%
  • Apollo Global Management, Inc.$1.6M +6.2%
Show all 40 →

Top Trims

  • Bristol-Myers Squibb Company-$710.9K -86.1%
  • LPL Financial Holdings Inc.-$316.0K -6.4%
  • DocGo, Inc.-$301.8K -18.0%
  • Viridian Therapeutics, Inc.-$215.4K -6.1%
  • Canadian Natural Resources Limited-$155.1K -18.9%
Show all 16 →

New Positions

  • Catalyst Pharmaceuticals, Inc.$3.6M
  • Spruce Biosciences, Inc.$1.1M
  • DuPont de Nemours, Inc.$511.0K
  • Insmed Incorporated$453.5K
  • LB Pharmaceuticals, Inc.$420.8K
Show all 11 →

Exited Positions

  • Catalyst Pharmaceuticals, Inc.$3.0M
  • Arcellx Inc$2.2M
  • Cytokinetics, Incorporated$1.6M
  • Centessa Pharmaceuticals PLC$1.5M
  • ADMA Biologics, Inc.$542.4K
Show all 12 →
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 Alphabet Inc-Cl C GOOG 02079K107 $32.2M 17.03% 91,200 SH
2 Apollo Global Management, Inc. APO 03769M106 $26.6M 14.07% 225,000 SH
3 Syndax Pharmaceutical, Inc. SNDX 87164F105 $9.6M 5.05% 437,245 SH
4 Xeris Biopharma Holdings, Inc. XERS 98422E103 $8.4M 4.44% 1,060,000 SH
5 Travere Therapeutics, Inc. TVTX 89422G107 $8.4M 4.42% 147,282 SH
6 Protagonist Therapeutics, Inc PTGX 74366E102 $7.7M 4.08% 63,000 SH
7 Bridgebio Pharma, Inc. BBIO 10806X102 $6.9M 3.66% 92,850 SH
8 Iovance Biotherapeutics, Inc. IOVA 462260100 $6.7M 3.52% 1,600,000 SH
9 Alkermes PLC ALKS G01767105 $6.4M 3.37% 121,759 SH
10 JPMorgan Chase & Co. JPM 46625H100 $5.9M 3.13% 18,098 SH
11 Janus Henderson AAA CLO ETF JAAA 47103U845 $4.7M 2.50% 93,528 SH
12 LPL Financial Holdings Inc. LPLA 52012V100 $4.6M 2.46% 16,500 SH
13 Cogent Biosciences Inc. COGT 19240Q201 $4.3M 2.27% 111,081 SH
14 TG Therapeutics, Inc. TGTX 88322Q108 $3.7M 1.94% 66,839 SH
15 Catalyst Pharmaceuticals, Inc. CLST 14888L101 $3.6M 1.89% 114,000 SH
16 Agios Pharmaceutical, Inc. AGIO 00847X104 $3.5M 1.86% 95,058 SH
17 Viridian Therapeutics, Inc. VRDN 92790C104 $3.3M 1.76% 181,000 SH
18 Relmada Therapeutics, Inc. RLMD 75955J402 $3.1M 1.65% 451,000 SH
19 Arcus Biosciences, Inc. RCUS 03969F109 $2.5M 1.32% 81,241 SH
20 Cybin Inc HELP 23256X407 $2.4M 1.29% 370,000 SH
21 SPDR S&P Biotech ETF XBI 78464A870 $2.4M 1.25% 15,000 SH
22 Rezolute, Inc. RZLT 76200L309 $1.9M 1.02% 370,000 SH
23 AllianceBernstein Holding L.P. AB 01881G106 $1.7M 0.89% 48,000 SH
24 Madrigal Pharmaaceuticals, Inc. MDGL 558868105 $1.6M 0.85% 3,000 SH
25 AtriCure, Inc. ATRC 04963C209 $1.4M 0.76% 51,400 SH
26 DocGo, Inc. DCGO 256086109 $1.4M 0.73% 2,670,850 SH
27 Ardelyx, Inc. ARDX 039697107 $1.3M 0.71% 263,168 SH
28 Ultragenyx Pharmaceutical Inc. RARE 90400D108 $1.3M 0.67% 38,069 SH
29 The Panagram BBB-B CLO ETF CLOZ 81752T528 $1.3M 0.67% 47,807 SH
30 Cullinan Therapeutics, Inc. CGEM 230031106 $1.3M 0.67% 69,182 SH
31 Vera Therapeutics, Inc. VERA 92337R101 $1.1M 0.59% 26,000 SH
32 Orchestra Biomed Holdings, Inc. OBIO 68572M106 $1.1M 0.58% 253,651 SH
33 Spruce Biosciences, Inc. SPRB 85209E208 $1.1M 0.57% 20,000 SH
34 Connect Biopharma Holdings Limited CNTB G23549101 $1.1M 0.56% 444,862 SH
35 iShares Biotechnology ETF IBB 464287556 $1.0M 0.55% 5,500 SH
36 Johnson & Johnson JNJ 478160104 $1.0M 0.54% 4,000 SH
37 Biogen Inc. BIIB 09062X103 $864.2K 0.46% 4,000 SH
38 Pfizer Inc. PFE 717081103 $778.7K 0.41% 32,337 SH
39 Apple Inc. AAPL 037833100 $721.7K 0.38% 2,494 SH
40 Canadian Natural Resources Limited CNQ 136385101 $663.6K 0.35% 16,800 SH
41 Pelthos Therapeutics, Inc. PTHS 171126204 $623.8K 0.33% 22,073 SH
42 International Business Machines IBM 459200101 $602.4K 0.32% 2,142 SH
43 Microsoft Corporation MSFT 594918104 $596.8K 0.32% 1,600 SH
44 Verastem Inc. VSTM 92337C203 $592.1K 0.31% 155,000 SH
45 Kura Oncology, Inc. KURA 50127T109 $578.9K 0.31% 52,767 SH
46 Solid Bioscience Inc. SLDB 83422E204 $561.5K 0.30% 56,208 SH
47 DuPont de Nemours, Inc. DD 36614N201 $511.0K 0.27% 3,767 SH
48 Insmed Incorporated INSM 457669307 $453.5K 0.24% 4,253 SH
49 LB Pharmaceuticals, Inc. LBRX 50180M108 $420.8K 0.22% 12,965 SH
50 CareDx, Inc. CDNA 14167L103 $388.5K 0.21% 13,630 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-12 $189.2M 86 0001104659-26-094536
2026-03-31 2026-05-14 $168.0M 88 0001104659-26-060750
2025-12-31 2026-02-12 $215.9M 91 0001104659-26-014058
2025-09-30 2025-11-12 $248.0M 92 0001104659-25-110124